Daniel L. Zabrowski
Geen lopende functies
Profiel
Daniel L.
Zabrowski founded M2SC Consulting LLC.
He is Executive Chairman for Nimble Therapeutics, Inc. He is also on the board of 8 other companies.
He previously occupied the position of Head-Roche Sequencing Solutions at Roche Holding AG President-Roche Sequencing Unit at Ventana Medical Systems, Inc. and Global Head-Drug Regulatory Affairs at Roche Pharma (Schweiz) AG (both are subsidiaries of Roche Holding AG), Associate Director at Fujisawa Healthcare, Inc., Executive Director-Drug Regulatory Affairs at Syntex (USA), Inc. and Research Investigator at G.D.
Searle LLC.
Daniel L.
Zabrowski received a doctorate from Indiana University and an undergraduate degree from St. Louis University.